News & Insights

JJIV Solve MIT Winners Banner v3_2.png

News & Insights

Reflections from Dawa Health, a 2022 MIT Health Access prize-winner

Catching up with Tafadzwa Kalisto Munzwa, CEO and Co-Founder of Dawa Health, an AI-powered health platform democratizing access to healthcare through community health workers.

3 Min Read

Learn More

VilCap Health Equity Alumni banner A.jpg

News & Insights

Doubling down on support for innovation that builds health equity

This year, JJIV launched the U.S. Health Equity Alumni program to further support founders from previous Village Capital programs.

8 Min Read

Learn More

Newsletter Signup Graphic_v1 (1).png

News & Insights

It takes a village

Message from Dana Deardorff - November 2023 JJIV Newsletter

2 Min Read

Learn More

Banner for Q&A with Wysa_ JJIV Website.jpg

News & Insights

Q&A with Wysa on innovations in mental healthcare

In light of World Mental Health Day earlier this month, we took the opportunity to speak with Wysa about the barriers people face in improving their mental health. Wysa provides users with an innovative digital platform for AI-driven, evidence-based mental health support, coaching and services. Based in Boston, MA, they have now reached over 11 million people across 95 countries. Wysa is a portfolio company of HealthQuad, one of our fund investments at Johnson & Johnson Impact Ventures, an impact fund within the Johnson & Johnson Foundation.

3 Min Read

Learn More

JJIV Website_ MIT Solve 2023_ Group.jpg

News & Insights

Meet the Winners of the 2023 MIT Solve Health Access Prize

For a second year running, Johnson & Johnson Impact Ventures, an impact investment fund within the Johnson & Johnson Foundation, funded the MIT Solve Health Access Prize to empower entrepreneurs around the world to implement innovative solutions tackling some of the greatest health inequities. This year’s Health Access Prize was awarded to four teams who participated in the Health in Fragile Contexts Challenge, which asked: How can we build resilience in health systems and maintain access to care despite destabilizing events?

4 Min Read

Learn More

News & Insights

MIT Solve Awards Over $1.5 Million in Funding to 31 Tech-Based Innovators Addressing Global Challenges (PRESS RELEASE)

CAMBRIDGE, MA / ACCESSWIRE / September 18, 2023 / MIT Solve, an initiative of the Massachusetts Institute for Technology with a mission to drive innovation to solve world challenges, unveiled its 2023 Solver class today -- 31 tech-innovators tackling its 2023 Global Challenges. This took place during Solve's annual pitch event in New York City ahead of the UN General Assembly Week. The 2023 Solvers share a prize pool of over $1.5 million, and each team receives at least $10,000 in unrestricted funding and enters a nine-month support program to scale their work and impact.

3 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures invests in Field Intelligence to improve health supply chain in Kenya and Nigeria

In Africa, over 1 billion people look to their local, community-based pharmacy for essential healthcare. Unfortunately, many of these patients are unable to receive quality healthcare because of the obstacles that pharmacies face managing data, accessing financing and fulfilling basic supply needs. The issue often comes down to fundamental logistical challenges of getting critical medicines and supplies to where the demand actually is. These challenges significantly impact the lives of patients and also place a heavy economic burden on pharmacies and health systems.

1 Min Read

Learn More

News & Insights

Founders Factory Africa to deploy $114M using learnings from past programs

This week, South African early-stage accelerator and investor Founders Factory Africa (FFA) raised $114 million. The firm plans to use the impact capital from Mastercard Foundation and Johnson & Johnson Impact Ventures “to scale its model to better serve founders across the African tech ecosystem.”

1 Min Read

Learn More

News & Insights

Quality Interactions Secures Major Investment to Expand Health Equity Training (PRESS RELEASE)

Backed by influential organizations, the company accelerates efforts to drive inclusive healthcare with online cultural competency and implicit bias training.

2 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Quality Interactions to Improve Equitable Healthcare in the U.S.

Preventable differences in health outcomes, known as health disparities, are a longstanding and persistent problem in the United States. And despite best intentions, healthcare professionals can contribute to these disparities, even when they are not aware that they are doing so. This is what is known as implicit (or unconscious) bias.

1 Min Read

Learn More

JJIV_Newsletter Post_Q2 2023 (1).jpg

News & Insights

Message from Dana Deardorff

July 2023 Newsletter

2 Min Read

Learn More

WhatsApp Image 2023-05-11 at 8.49.42 PM (1).jpeg

News & Insights

More than Capital: Drawing on Johnson & Johnson Expertise to Help Portfolio Companies Succeed

JJIV portfolio companies leverage an employee secondment program to tap into J&J's wide network of market knowledge and subject matter expertise.

5 Min Read

Learn More

RockHealth summit panel.jpg

News & Insights

Unlocking Opportunity for Impact in Digital Health With Diverse Entrepreneurs

The remarkable growth of the digital health innovation market comes alongside concerning data that investors are missing some of the biggest opportunities—to the detriment of public health overall. How can investors ensure they are acting on the promise of digital health to impact the lives of all?

1 Min Read

Learn More

Mamotest Argentina patients.JPG

News & Insights

AI is Revolutionizing Healthcare… But for Whom?

Guillermo Pepe, founder and CEO of Mamotest, elaborates on the opportunity of using AI to expand access to healthcare in new ways, and their unique approach as a tech company that is still human-centric and focused on patient care.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Mamotest to Improve Access to Care for Breast Cancer Patients in Latin America

Breast cancer is the most common type of cancer worldwide, but when caught early enough, has a 98% survival rate. Unfortunately, in many countries and rural areas, there are significant challenges with access, awareness, high costs and poor-quality diagnostics—all leading to undiagnosed patients or late-stage detection, where the survival rate can drop to as low as 40%. Even after diagnosis, fragmented and confusing healthcare systems block many patients from getting the treatments and care they need to survive. This is why access to early, high-quality exams and continuity of treatment support are crucial to saving patients’ lives.

2 Min Read

Learn More

News & Insights

Mamotest secures $3.3 million for breast cancer screening in Latin America

The company raised $3.3 million in pre-Series A funding from Johnson & Johnson Impact Ventures, Merck, Sonen Capital and venture capital firm Sky High.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Founders Factory Africa to Build and Scale Healthcare Startups in Africa

Although Africa does not suffer from a lack of entrepreneurial interest, innovation still faces major challenges. In particular, it’s often difficult for founders to get funding and other needed support when their businesses are in early stages of development. Most funding in Africa goes to lower-risk, later-stage companies, and early-stage African entrepreneurs receive only 8% of total investment dollars compared to 20-25% in other startup-supportive economies.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Clinify Health to Support Financial Sustainability of Community Health Centers in the U.S. and to Improve Patient Health Outcomes

Federally Qualified Health Centers (FQHCs) provide comprehensive primary care and ancillary services to almost 90 million patients in the United States. They play a critical role in bridging the gap to reach under-resourced communities and improving their health. However, FQHCs are often reimbursed on a per patient encounter basis, rather than the measures tied to patient’s overall health, engagement and costs. Ultimately, this antiquated reimbursement model encourages quantity over quality, limiting providers’ ability to ensure enough time, resources and management of that patient’s care is closely tied to the medical complexity of the patients themselves.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Penda Health to Expand Access to Primary Healthcare in Kenya

Like many countries in Africa, Kenya has a low doctor-to-patient ratio, and millions of people do not have access to healthcare that is both high-quality and affordable. Penda Health was founded with a mission to bridge the gap between costly private healthcare and overcrowded public facilities, providing a new model for delivering care to families and underserved communities.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Certintell Telehealth to Increase the Capacity of Community-Based Health Centers in the U.S.

In the United States, 60% of people have chronic health conditions such as diabetes, heart disease and cancer. Black, Indigenous and Latino Americans are two times as likely to suffer from these conditions. Many of these diverse groups rely on community-based organizations for their care, including nearly 1,500 Federally Qualified Health Centers (FQHCs) serving about 32 million people around the country. However, these health centers also face staffing and capacity issues due to healthcare worker burnout.

1 Min Read

Learn More

JW & DD promo.jpg

News & Insights

From Idea to Investment to Impact: Q&A Between Joe Wolk and Dana Deardorff

Dana Deardorff, Global Director, for Johnson & Johnson Impact Ventures (JJIV), an impact fund within the Johnson & Johnson Foundation, covers JJIV’s investment thesis, trends in the HealthTech space and what entrepreneurs need to succeed in today’s environment with Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson and Investment Committee Chairman for Johnson & Johnson Impact Ventures.

6 Min Read

Learn More

JJIV - VilCap Q&A Banner - March 2023.png

News & Insights

Flipping the Scripts: Village Capital Lets Startups Choose Who Wins Funding

In 2009, Village Capital, the world’s largest organization supporting impact-driven, seed-stage startups, began exploring solutions to a challenge they saw blocking progress toward racial equity in venture capital. They noticed a systemic reliance on “pattern recognition” among most venture capital firms, in which investors—a predominantly White and male population—were more likely to support those that looked like them.

5 Min Read

Learn More

Villgro Article 1 Option D_ Zuri Health Screenshot 2.jpg

News & Insights

Partnering with Villgro Africa to Support Health Workers Across the Continent

In 2021, Villgro Africa and JJIV partnered to launch an incubation program for startups in Africa whose solutions support frontline health workers (FLHW). A total of 65 applications were received from seven East African countries: Ethiopia, Kenya, Rwanda, Somalia, Tanzania and Uganda. From this pool of candidates, Benacare, Streamline Health and Zuri Health won funding and incubation support for their outstanding innovations supporting frontline health workers across the continent.

1 Min Read

Learn More

News & Insights

Certintell Telehealth Receives New Funding to Expand Virtual Care Services to More Communities (PRESS RELEASE)

The company plans to support more health providers and patients with chronic conditions

1 Min Read

Learn More

News & Insights

SwipeRx boosts Series B to $37 Million to Accelerate its B2B Pharmacy Platform Across Southeast Asia

This new round marks an investment from marquee investors such as global pharma Sanofi’s Global Health Unit and Cercano (formerly Microsoft co-founder Paul Allen’s Vulcan Capital) with strong participation from existing investors. Fresh funds to be deployed towards expanding Business to Business (B2B) commerce for pharmacies, investing in specialised healthcare logistics and financing and accelerating adoption of its new point of sale and inventory management solutions. SwipeRx will further grow its current network of over 250,000+ pharmacy professionals and 50,000+ pharmacies in Southeast Asia. 1 in every 3 pharmacists in Southeast Asia is on SwipeRx.Read the entire article on the SwipeRx website.

1 Min Read

Learn More

Doctor,Consulting,Patient,With,Digital,Tablet,,Discussing,Diagnosis,And,Medical

News & Insights

Trust, Not Technology, Bonds Patients and Providers

JJIV is committed to transforming health systems and driving equitable healthcare by not just investing in a technology, service or delivery mechanism, but also the people behind them who have demonstrated interest and commitment to building trust into their market-driven solutions.

1 Min Read

Learn More

Image 1.JPG

News & Insights

Potential for Impact: Pharmacies are the Key to Improving Community Health in Southeast Asia

Based in Singapore, SwipeRx has grown into the largest digital pharmacy network across Southeast Asia, with a mobile app enabling pharmacies to operate more efficiently by acquiring supplies directly from the platform. Johnson & Johnson Impact Ventures, a fund within the Johnson & Johnson Foundation, supports SwipeRx in its work connecting over 245,000 pharmacy professionals who together build public health across the region.

4 Min Read

Learn More

Echoing Green Hero Image.jpg

News & Insights

At the Intersection of Health & Equity: Meet the 2022 Echoing Green Fellows

We’re excited to share the latest cohort of Echoing Green Fellows using the market to resolve health inequities and transform health and healthcare worldwide.

3 Min Read

Learn More

impact alpha nov 22 article.jpg

News & Insights

How Shared Accountability Can Increase the Social Impact of Healthcare Investing

Delivering real impact that improves health outcomes for underserved communities requires innovators and investors to make their expectations and standards explicit and then to share a sense of accountability to those expectations.

1 Min Read

Learn More

Emtithal Mahmoud (Speetar) and Doreen Toutikian (omgyno).jpg

News & Insights

Meet the Winners of the Health Access Prize!

Around the world, entrepreneurs are pushing the boundaries of what’s possible and spearheading solutions to health problems they see in their communities.

4 Min Read

Learn More

Load more

Subscribe to Our Newsletter

First Name

Last Name

Email

Organization

Country (Optional)